It's too soon for Canadian cannabis producers to put dollar figures on European markets on the cusp of legalizing recreational pot, according to an industry executive with experience on both sides of the Atlantic.

Deepak Anand is chief executive officer of Materia, a London-based processor and distributor of medical cannabis and CBD wellness products. The company spans the UK, Germany, Denmark, and Malta. Prior to shifting focus to Europe, Anand established himself as a popular commentator on the industry in Canada, and served as vice-president of a consulting firm acquired by Deloitte.

Canopy Growth Stock’s Prospects in 2022

History may not always repeat itself, but it does at the very least rhyme. Once again, marijuana stocks have begun to rally after being incorrectly devalued.

One of those marijuana stocks is Canopy Growth Corp (NYSE:CGC), perhaps the pot stock I’ve written about the most. CGC stock was one of the first marijuana stocks I began covering, and the company was always good for a headline-grabbing acquisition or new product announcement (or at least it used to be).

But Canopy Growth stock has fallen on hard times as of late.

After such a promising start to the year it’s safe to say that 2021 has been a bust for Canadian cannabis. Most names in the space now down by plenty, which seems to speak to the market’s skepticism about both growth prospects in the maturing industry and the current glut of pot product and pot companies trying to elbow their way into market share. 

There are roughly two camps to the Canadian picture, the bigger players with billion-dollar market caps and then there’s the rest, which means medium-sized and smaller operations now trying to pull away market share from the larger operations. 

Although cannabis is legal at the federal level in Canada, main retail store owners are having trouble accessing basic financial services. These operators are unable to access simple services like opening checking accounts and we believe this aspect of the industry needs to change. (article available here)   

The limited access to capital is stifling the growth of the Canadian cannabis sector and we are surprised that licensed businesses are facing this issue. One of the main issues with this problem is related to how it is supporting the growth of the black market in Canada.

he University of Queensland has struck a deal with Canadian health and wellness company PreveCeutical Medical which could revolutionize the way patients take medical cannabis. Invented at the UQ School of Pharmacy by Dr Harendra Parekh and his team, the Sol-Gel technology is a liquid solution that converts to a gel upon contact with the internal membranes of the human body, such as the nose. UQ's commercialization company, UniQuest, granted PreveCeutical the rights to use the Sol-Gel technology for the specific delivery of cannabinoids to all regions and membranes of the human body.

The deal executed by UniQuest includes a license to the patent application.

Canada's legal weed industry needs innovation, not more regulation, say entrepreneurs

Despite his success, Samuel Gerges has a hard time even opening a business account.

Just weeks after Canada’s third anniversary of legal recreational cannabis, the country — particularly at the local level — is dealing with the realities of a post-legalization world.

A survey conducted, between 2018-2019, by the government determined that over 18% of Canadians regularly consumed cannabis-based products — including legalized CBD substances.

The medium annual spending, per capita, for CBD products in Canada, is over $1500. And, what’s an even more telling statistic, is that most Canadians like to purchase their product online.

That’s why weed delivery in Toronto is such a hot topic right now. In this article, we’re going to talk about online dispensaries and Toronto weed delivery trends.

After a weak start and a subsequent recovery that lifted it into positive territory for a few minutes, the Canadian stock market slipped into the red Monday morning, weighed down by losses in healthcare and technology shares.Energy stocks are up firmly in positive territory, while a few stocks from telecom and financial sectors are up with notable gains. Shares from other sectors are mostly subdued in cautious trade.Worries about growth due to the spread of the coronavirus cases in several parts across Europe and lockdown restriction in some countries appear to be weighing on sentiment.

The benchmark S&P/TSX Composite Index is down 108.51 points or 0.5% at 21,446.52 a few minutes past noon.

Health Canada-approved buds included in drugs found after 16-month investigation, police say

Ontario police have charged 21 people after seizing cannabis valued at $32 million that allegedly includes Health Canada-approved marijuana, as part of an investigation that began in June 2020.

Ontario Provincial Police worked with multiple police forces as part of Operation Gainsborough.

On Tuesday, investigators described how the accused were running websites selling cannabis from registered growers, and delivering the drugs to customers in London, Kitchener, Hamilton and Toronto. Police allege products were also being sold internationally.